And for our folks in the audience, well mention observational trials a couple times throughout this episode
Ageing Research Reviews 94, 102201
[1] [5] Other common gastrointestinal effects include vomiting, diarrhea, abdominal pain, and constipation
Insurers are putting up roadblocks to help patients: Among those with coverage for weight loss, 90% have a policy requiring prior authorization
The pharmaceutical industry caught on, and new drugs followed
The platforms particular differentiator is its emphasis on microdosing GLP-1 medications, offering lower-dose entry points alongside standard weight loss protocols for patients who prefer a gentler titration approach or who want GLP-1s for longevity and metabolic support rather than rapid weight loss